In compliance of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has submitted a copy of the published extract of consolidated audited financial results for the quarter and financial year ended 31.03.2021 along with information of Standalone Financial Results. The same have been published on Wednesday, 09.06.2021 in the Ahmedabad edition of Financial Express (English) and Financial Express (Gujarati).
The above information is a part of company’s filings submitted to BSE.